Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
about
Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities StudyExperimental Biology for the Identification of Causal Pathways in Atherosclerosis.Drugs that Affect Cardiac Metabolism: Focus on Perhexiline.SP and KLF Transcription Factors in Digestive Physiology and Diseases.The KLF14 transcription factor regulates hepatic gluconeogenesis in mice.Novel Approaches for HDL-Directed Therapies.HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.Krüppel-like factors and vascular wall homeostasis.Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition.Krüppel-like factors: Crippling and un-crippling metabolic pathways.Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease.
P2860
Q38372740-A0C33A89-D667-4214-A525-7E9A49715101Q38723704-BD154702-C58A-4BB9-8137-742615FB3D18Q38815503-6194ECCA-6375-4ED4-A98E-EFF89E1C212EQ39214035-7A9AFDE6-428F-4A6B-98C5-0D7E47DF9EC4Q47419146-A5ECE43B-6100-4206-A8F8-A49812B38E1CQ47441104-CC9C8C27-E647-4444-83F6-32FE344EB56AQ47657807-3CAB3D22-9A53-420E-867E-8A1E1B796448Q47676828-D1F3D594-2B09-4EBB-A71B-9ADB1C7A718FQ48526348-EBE11974-618F-49DA-8031-4AD46380B3BCQ49247394-1532D475-C747-4231-97E5-6DC96C9B9C03Q53697033-9D355C17-AC80-48E1-92B7-EBE28EFE2667Q55079168-E98B6179-6CB5-4F10-81E1-554ED3B100D7Q55250888-0CFCB8A5-1243-47DA-8EEA-06EC0C9682F4
P2860
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
@ast
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
@en
type
label
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
@ast
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
@en
prefLabel
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
@ast
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
@en
P2093
P2860
P356
P1476
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
@en
P2093
Angela J Mathison
Cristen J Willer
Daniel J Rader
Gwen A Lomberk
Jifeng Zhang
Lixia Zeng
Minerva T Garcia-Barrio
P2860
P304
P356
10.1172/JCI79048
P407
P50
P577
2015-09-14T00:00:00Z